Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1162-2018

Drug recall · September 5, 2018

Methyl-Cobalamin injectable recall

Why: Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Methyl-Cobalamin injectable, 10 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

Lots / codes

Lot #: 180702/1, Exp 30-Sep-18

Quantity
81 vials
Company
Auro Pharmacies, Inc., La Habra, CA
Distribution
Nationwide in USA
Initiated
August 21, 2018 · Voluntary: Firm initiated
Classified
August 29, 2018
Reported
September 5, 2018
Ended
January 30, 2020
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.